Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and the prolonged use of glucocorticoids is associated with side effects. The effect of the interleukin-6 receptor alpha inhibitor tocilizumab on the rates of relapse during glucocorticoid tapering was studied in patients with giant-cell arteritis.

Trial of Tocilizumab in Giant-Cell Arteritis / Stone, John H; Tuckwell, Katie; Dimonaco, Sophie; Klearman, Micki; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria C; Dasgupta, Bhaskar; Rech, Juergen; Salvarani, Carlo; Schett, Georg; Schulze Koops, Hendrik; Spiera, Robert; Unizony, Sebastian H; Collinson, Neil. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 377:4(2017), pp. 317-328. [10.1056/NEJMoa1613849]

Trial of Tocilizumab in Giant-Cell Arteritis

SALVARANI, CARLO;
2017

Abstract

Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and the prolonged use of glucocorticoids is associated with side effects. The effect of the interleukin-6 receptor alpha inhibitor tocilizumab on the rates of relapse during glucocorticoid tapering was studied in patients with giant-cell arteritis.
2017
377
4
317
328
Trial of Tocilizumab in Giant-Cell Arteritis / Stone, John H; Tuckwell, Katie; Dimonaco, Sophie; Klearman, Micki; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria C; Dasgupta, Bhaskar; Rech, Juergen; Salvarani, Carlo; Schett, Georg; Schulze Koops, Hendrik; Spiera, Robert; Unizony, Sebastian H; Collinson, Neil. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 377:4(2017), pp. 317-328. [10.1056/NEJMoa1613849]
Stone, John H; Tuckwell, Katie; Dimonaco, Sophie; Klearman, Micki; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria C; Dasgupta, Bha...espandi
File in questo prodotto:
File Dimensione Formato  
nejmoa1613849.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 268.09 kB
Formato Adobe PDF
268.09 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1144713
Citazioni
  • ???jsp.display-item.citation.pmc??? 257
  • Scopus 878
  • ???jsp.display-item.citation.isi??? 820
social impact